Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Inès J Beumer"'
Autor:
Inès J. Beumer, Marion Persoon, Anke Witteveen, Christa Dreezen, Suet-Feung Chin, Stephen-John Sammut, Mireille Snel, Carlos Caldas, Sabine Linn, Laura J. van 't Veer, Rene Bernards, Annuska M. Glas
Publikováno v:
Biomarker Insights, Vol 2016, Iss 11, Pp 139-146 (2016)
Externí odkaz:
https://doaj.org/article/2e3de5bac305406db4c3434460a6f8e8
Autor:
Härkönen, Lan Yu, Mervi Toriseva, Syeda Afshan, Mario Cangiano, Vidal Fey, Andrew Erickson, Heikki Seikkula, Kalle Alanen, Pekka Taimen, Otto Ettala, Martti Nurmi, Peter J. Boström, Markku Kallajoki, Johanna Tuomela, Tuomas Mirtti, Inès J. Beumer, Matthias Nees, Pirkko
Publikováno v:
Cancers; Volume 14; Issue 2; Pages: 278
Fibroblast growth factor receptors (FGFRs) 1–4 are involved in prostate cancer (PCa) regulation, but the role of FGFR-like 1 (FGFRL1) in PCa is unclear. FGFRL1 expression was studied by qRT-PCR and immunohistochemistry of patient tissue microarrays
Autor:
Lan Yu, Mervi Toriseva, Syeda Afshan, Mario Cangiano, Vidal Fey, Andrew Erickson, Heikki Seikkula, Kalle Alanen, Pekka Taimen, Otto Ettala, Martti Nurmi, Peter J. Boström, Markku Kallajoki, Johanna Tuomela, Tuomas Mirtti, Inès J. Beumer, Matthias Nees, Pirkko Härkönen
Publikováno v:
Cancers
Cancers, Vol 14, Iss 278, p 278 (2022)
Cancers, Vol 14, Iss 278, p 278 (2022)
Simple Summary Prostate cancer (PCa) is one of the most frequently diagnosed malignancies in men. PCa is primarily regulated by androgens, but other mechanisms, such as fibroblast growth factor receptor (FGFR) signaling, are also involved. In some pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f298e53db9bf3d98b939f4bc26c31296
https://trepo.tuni.fi/handle/10024/144754
https://trepo.tuni.fi/handle/10024/144754
Autor:
Hing Y. Leung, Inès J Beumer, Mario Cangiano, Guido Jenster, Alfonso Urbanucci, Graham Hamilton, Magda Grudniewska, Matti Nykter, Zoraide Granchi, Bart Janssen, Mark Salji
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, 13(9):2094. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 2094, p 2094 (2021)
Volume 13
Issue 9
Cancers, 13(9):2094. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 2094, p 2094 (2021)
Simple Summary Prostate cancer is a very common malignancy worldwide. Treatment resistant prostate cancer poses a big challenge to clinicians and is the second most common cause of premature death in men with cancer. Gene expression analysis has been
Autor:
Van Hemelryk, Annelies1 (AUTHOR), Tomljanovic, Ingrid1,2 (AUTHOR), de Ridder, Corrina M. A.1 (AUTHOR), Stuurman, Debra C.1 (AUTHOR), Teubel, Wilma J.1 (AUTHOR), Erkens-Schulze, Sigrun1 (AUTHOR), Verhoef, Esther I.3 (AUTHOR), Remmers, Sebastiaan1 (AUTHOR), Mahes, Amrish J.2 (AUTHOR), van Leenders, Geert J. L. H.3 (AUTHOR), van Royen, Martin E.3 (AUTHOR), van de Werken, Harmen J. G.1,4,5 (AUTHOR), Grudniewska, Magda2 (AUTHOR), Jenster, Guido W.1 (AUTHOR), van Weerden, Wytske M.1 (AUTHOR) w.vanweerden@erasmusmc.nl
Publikováno v:
Cells (2073-4409). Nov2022, Vol. 11 Issue 22, p3632. 21p.
Autor:
Yu, Lan1 (AUTHOR) yulan@zzu.edu.cn, Toriseva, Mervi1 (AUTHOR) mertor@utu.fi, Afshan, Syeda1 (AUTHOR) syeda.afshan@utu.fi, Cangiano, Mario2 (AUTHOR) mario.cangiano@biogemcampus.com, Fey, Vidal1 (AUTHOR) vidal.fey@tuni.fi, Erickson, Andrew3 (AUTHOR) andrew.erickson@helsinki.fi, Seikkula, Heikki4 (AUTHOR) heikki.seikkula@ksshp.fi, Alanen, Kalle5 (AUTHOR) kalle.a.alanen@gmail.com, Taimen, Pekka1,5 (AUTHOR) markku.kallajoki@tyks.fi, Ettala, Otto4 (AUTHOR) otto.ettala@tyks.fi, Nurmi, Martti4 (AUTHOR) Martti.nurmi@fimnet.fi, Boström, Peter J.4 (AUTHOR) peter.j.bostrom@gmail.com, Kallajoki, Markku5 (AUTHOR), Tuomela, Johanna1 (AUTHOR) matthias.nees@utu.fi, Mirtti, Tuomas6 (AUTHOR) tuomas.mirtti@helsinki.fi, Beumer, Inès J.2 (AUTHOR) i.beumer@genomescan.nl, Nees, Matthias1,7 (AUTHOR), Härkönen, Pirkko1 (AUTHOR) harkonen@utu.fi
Publikováno v:
Cancers. Feb2022, Vol. 14 Issue 2, p278-278. 1p.
Autor:
Cangiano, Mario1 (AUTHOR) 2352539C@student.gla.ac.uk, Grudniewska, Magda1 (AUTHOR) m.grudniewska@genomescan.nl, Salji, Mark J.2,3 (AUTHOR) Mark.Salji@ggc.scot.nhs.uk, Nykter, Matti4 (AUTHOR) matti.nykter@uta.fi, Jenster, Guido5 (AUTHOR) g.jenster@erasmusmc.nl, Urbanucci, Alfonso6 (AUTHOR) alfonsou@ifi.uio.no, Granchi, Zoraide1 (AUTHOR) zoraide.granchi@gmail.com, Janssen, Bart1 (AUTHOR) b.janssen@genomescan.nl, Hamilton, Graham7 (AUTHOR) Graham.Hamilton@glasgow.ac.uk, Leung, Hing Y.2,3 (AUTHOR) h.leung@beatson.gla.ac.uk, Beumer, Inès J.1 (AUTHOR) h.leung@beatson.gla.ac.uk, Krainer, Michael W. (AUTHOR)
Publikováno v:
Cancers. May2021, Vol. 13 Issue 9, p2094-2094. 1p.
Autor:
In 't Veld SGJG; Department of Neurosurgery, VU University Medical Center, 1081HV Amsterdam, The Netherlands. g.intveld1@vumc.nl., Duong KN; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. kim.duong@agendia.com., Snel M; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. mireille.snel@agendia.com., Witteveen A; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. anke.witteveen@agendia.com., Beumer IJ; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. ines.beumer@agendia.com., Delahaye LJMJ; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. leonie.delahaye@agendia.com., Wehkamp D; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. diederik.wehkamp@agendia.com., Bernards R; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. r.bernards@nki.nl.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands. r.bernards@nki.nl., Glas AM; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. annuska.glas@agendia.com., Tian S; Agendia NV, Science Park 406, 1098XH Amsterdam, The Netherlands. sun.tian@agendia.com.
Publikováno v:
High-throughput [High Throughput] 2017 Nov 06; Vol. 6 (4). Date of Electronic Publication: 2017 Nov 06.